RU2003122217A - DIPHENYLAZETIDINONE DERIVATIVES, METHODS FOR THEIR PRODUCTION, MEDICINES CONTAINING THESE COMPOUNDS, AND THEIR APPLICATION - Google Patents
DIPHENYLAZETIDINONE DERIVATIVES, METHODS FOR THEIR PRODUCTION, MEDICINES CONTAINING THESE COMPOUNDS, AND THEIR APPLICATIONInfo
- Publication number
- RU2003122217A RU2003122217A RU2003122217/04A RU2003122217A RU2003122217A RU 2003122217 A RU2003122217 A RU 2003122217A RU 2003122217/04 A RU2003122217/04 A RU 2003122217/04A RU 2003122217 A RU2003122217 A RU 2003122217A RU 2003122217 A RU2003122217 A RU 2003122217A
- Authority
- RU
- Russia
- Prior art keywords
- alkyl
- phenyl
- substituted
- conh
- agonists
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title claims 12
- 239000003814 drug Substances 0.000 title claims 10
- 238000004519 manufacturing process Methods 0.000 title claims 2
- VDOXIAUNJCHYRC-UHFFFAOYSA-N 1,3-diphenylazetidin-2-one Chemical class O=C1C(C=2C=CC=CC=2)CN1C1=CC=CC=C1 VDOXIAUNJCHYRC-UHFFFAOYSA-N 0.000 title 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 146
- 229910052731 fluorine Inorganic materials 0.000 claims 32
- 229910052794 bromium Inorganic materials 0.000 claims 24
- 229910052801 chlorine Inorganic materials 0.000 claims 24
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 24
- 239000000556 agonist Substances 0.000 claims 21
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 claims 16
- 229910052740 iodine Inorganic materials 0.000 claims 16
- 125000000896 monocarboxylic acid group Chemical group 0.000 claims 16
- 229920000728 polyester Polymers 0.000 claims 16
- 125000002947 alkylene group Chemical group 0.000 claims 10
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 8
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims 8
- -1 CF 3 Inorganic materials 0.000 claims 8
- 125000002252 acyl group Chemical group 0.000 claims 8
- 125000004432 carbon atoms Chemical group C* 0.000 claims 8
- 239000011737 fluorine Substances 0.000 claims 8
- 125000001153 fluoro group Chemical group F* 0.000 claims 8
- 229910052739 hydrogen Inorganic materials 0.000 claims 8
- 125000004435 hydrogen atoms Chemical group [H]* 0.000 claims 8
- 239000003112 inhibitor Substances 0.000 claims 8
- 230000002401 inhibitory effect Effects 0.000 claims 8
- 201000002674 obstructive nephropathy Diseases 0.000 claims 8
- 125000000217 alkyl group Chemical group 0.000 claims 7
- 239000000126 substance Substances 0.000 claims 7
- 229940079593 drugs Drugs 0.000 claims 5
- 150000003839 salts Chemical class 0.000 claims 4
- 239000011780 sodium chloride Substances 0.000 claims 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N (3β)-Cholest-5-en-3-ol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims 3
- 230000003042 antagnostic Effects 0.000 claims 3
- 239000005557 antagonist Substances 0.000 claims 3
- 239000004367 Lipase Substances 0.000 claims 2
- 229940040461 Lipase Drugs 0.000 claims 2
- 206010061227 Lipid metabolism disease Diseases 0.000 claims 2
- 239000000637 Melanocyte-Stimulating Hormone Substances 0.000 claims 2
- 102000024367 PPAR alpha Human genes 0.000 claims 2
- 108010028924 PPAR alpha Proteins 0.000 claims 2
- 102000000536 PPAR gamma Human genes 0.000 claims 2
- 108010016731 PPAR gamma Proteins 0.000 claims 2
- 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 claims 2
- 239000003613 bile acid Substances 0.000 claims 2
- 201000000522 chronic kidney disease Diseases 0.000 claims 2
- 239000000122 growth hormone Substances 0.000 claims 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims 2
- 102000004882 lipase Human genes 0.000 claims 2
- 108090001060 lipase Proteins 0.000 claims 2
- 235000019421 lipase Nutrition 0.000 claims 2
- 230000000051 modifying Effects 0.000 claims 2
- 125000004430 oxygen atoms Chemical group O* 0.000 claims 2
- 102000004257 potassium channel family Human genes 0.000 claims 2
- 108020001213 potassium channel family Proteins 0.000 claims 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 claims 2
- KWTSXDURSIMDCE-QMMMGPOBSA-N (S)-amphetamine Chemical compound C[C@H](N)CC1=CC=CC=C1 KWTSXDURSIMDCE-QMMMGPOBSA-N 0.000 claims 1
- ZOBPZXTWZATXDG-UHFFFAOYSA-N 1,3-thiazolidine-2,4-dione Chemical compound O=C1CSC(=O)N1 ZOBPZXTWZATXDG-UHFFFAOYSA-N 0.000 claims 1
- SWLAMJPTOQZTAE-UHFFFAOYSA-N 4-[2-[(5-chloro-2-methoxybenzoyl)amino]ethyl]benzoic acid Chemical compound COC1=CC=C(Cl)C=C1C(=O)NCCC1=CC=C(C(O)=O)C=C1 SWLAMJPTOQZTAE-UHFFFAOYSA-N 0.000 claims 1
- 102000004146 ATP citrate synthases Human genes 0.000 claims 1
- 108090000662 ATP citrate synthases Proteins 0.000 claims 1
- ZKHQWZAMYRWXGA-KQYNXXCUSA-N Adenosine triphosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-N 0.000 claims 1
- 229940025084 Amphetamine Drugs 0.000 claims 1
- DNDCVAGJPBKION-DOPDSADYSA-N Bombesin Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(N)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC=1NC2=CC=CC=C2C=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1NC(=O)CC1)C(C)C)C1=CN=CN1 DNDCVAGJPBKION-DOPDSADYSA-N 0.000 claims 1
- 102000013585 Bombesin Human genes 0.000 claims 1
- 108010051479 Bombesin Proteins 0.000 claims 1
- OZVBMTJYIDMWIL-AYFBDAFISA-N Bromocriptine Chemical compound C1=CC(C=2[C@H](N(C)C[C@@H](C=2)C(=O)N[C@]2(C(=O)N3[C@H](C(N4CCC[C@H]4[C@]3(O)O2)=O)CC(C)C)C(C)C)C2)=C3C2=C(Br)NC3=C1 OZVBMTJYIDMWIL-AYFBDAFISA-N 0.000 claims 1
- 229960002802 Bromocriptine Drugs 0.000 claims 1
- 229940107161 Cholesterol Drugs 0.000 claims 1
- 101700002119 GAL Proteins 0.000 claims 1
- 102000018997 Growth Hormone Human genes 0.000 claims 1
- 108010051696 Growth Hormone Proteins 0.000 claims 1
- 102100013818 HCRT Human genes 0.000 claims 1
- 101710023151 HCRT Proteins 0.000 claims 1
- 206010062060 Hyperlipidaemia Diseases 0.000 claims 1
- 102000004877 Insulin Human genes 0.000 claims 1
- 108090001061 Insulin Proteins 0.000 claims 1
- 206010022489 Insulin resistance Diseases 0.000 claims 1
- 102000000853 LDL receptors Human genes 0.000 claims 1
- 108010001831 LDL receptors Proteins 0.000 claims 1
- 102000016267 Leptin Human genes 0.000 claims 1
- 108010092277 Leptin Proteins 0.000 claims 1
- NRYBAZVQPHGZNS-ZSOCWYAHSA-N Leptin Chemical compound O=C([C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)CCSC)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(O)=O NRYBAZVQPHGZNS-ZSOCWYAHSA-N 0.000 claims 1
- 102000017055 Lipoprotein lipase Human genes 0.000 claims 1
- 108010013563 Lipoprotein lipase Proteins 0.000 claims 1
- 102000004895 Lipoproteins Human genes 0.000 claims 1
- 108090001030 Lipoproteins Proteins 0.000 claims 1
- 229950004994 Meglitinide Drugs 0.000 claims 1
- 102000003728 Peroxisome Proliferator-Activated Receptors Human genes 0.000 claims 1
- 108090000029 Peroxisome Proliferator-Activated Receptors Proteins 0.000 claims 1
- 229940076279 Serotonin Drugs 0.000 claims 1
- 102100010746 TXNRD2 Human genes 0.000 claims 1
- 108010071769 Thyroid Hormone Receptors beta Proteins 0.000 claims 1
- 102100017892 UCN Human genes 0.000 claims 1
- 101710034481 UCN Proteins 0.000 claims 1
- 239000006096 absorbing agent Substances 0.000 claims 1
- 239000003888 alpha glucosidase inhibitor Substances 0.000 claims 1
- 229960002734 amfetamine Drugs 0.000 claims 1
- 239000003392 amylase inhibitor Substances 0.000 claims 1
- 230000000111 anti-oxidant Effects 0.000 claims 1
- 239000003472 antidiabetic agent Substances 0.000 claims 1
- 239000003963 antioxidant agent Substances 0.000 claims 1
- 229940058933 biguanide antimalarials Drugs 0.000 claims 1
- 229940090145 biguanide blood glucose lower drugs Drugs 0.000 claims 1
- 150000004283 biguanides Chemical class 0.000 claims 1
- 235000012000 cholesterol Nutrition 0.000 claims 1
- 239000003354 cholesterol ester transfer protein inhibitor Substances 0.000 claims 1
- 230000001419 dependent Effects 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 claims 1
- 230000002218 hypoglycaemic Effects 0.000 claims 1
- 239000000411 inducer Substances 0.000 claims 1
- 229940039781 leptin Drugs 0.000 claims 1
- 230000037356 lipid metabolism Effects 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 230000002474 noradrenergic Effects 0.000 claims 1
- 229940096700 plain lipid modifying drugs Fibrates Drugs 0.000 claims 1
- 229940096701 plain lipid modifying drugs HMG CoA reductase inhibitors Drugs 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 229960000854 protirelin Drugs 0.000 claims 1
- XNSAINXGIQZQOO-SRVKXCTJSA-N protirelin Chemical compound NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H]1NC(=O)CC1)CC1=CN=CN1 XNSAINXGIQZQOO-SRVKXCTJSA-N 0.000 claims 1
- 238000011084 recovery Methods 0.000 claims 1
- 239000000952 serotonin receptor agonist Substances 0.000 claims 1
- 239000004059 squalene synthase inhibitor Substances 0.000 claims 1
- YROXIXLRRCOBKF-UHFFFAOYSA-N sulfonylurea Chemical compound OC(=N)N=S(=O)=O YROXIXLRRCOBKF-UHFFFAOYSA-N 0.000 claims 1
- 239000000777 urocortin Substances 0.000 claims 1
Claims (15)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10064402.3 | 2000-12-21 | ||
DE10064402A DE10064402A1 (en) | 2000-12-21 | 2000-12-21 | New diphenyl-azetidinone derivatives useful for the treatment of hyperlipidemia, arteriosclerosis and hypercholesterolemia |
DE10154518.5 | 2001-11-07 |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2003122217A true RU2003122217A (en) | 2004-12-27 |
RU2282628C2 RU2282628C2 (en) | 2006-08-27 |
Family
ID=7668537
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2003122219/04A RU2275370C2 (en) | 2000-12-21 | 2001-12-11 | Derivatives of diphenylazethidinone, medicinal agents comprising these compounds and their using |
RU2003122217/04A RU2282628C2 (en) | 2000-12-21 | 2001-12-11 | Derivatives of diphenylazethidinone, pharmaceutical composition based on thereof and method for its preparing |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2003122219/04A RU2275370C2 (en) | 2000-12-21 | 2001-12-11 | Derivatives of diphenylazethidinone, medicinal agents comprising these compounds and their using |
Country Status (3)
Country | Link |
---|---|
DE (1) | DE10064402A1 (en) |
RU (2) | RU2275370C2 (en) |
ZA (2) | ZA200304092B (en) |
-
2000
- 2000-12-21 DE DE10064402A patent/DE10064402A1/en not_active Withdrawn
-
2001
- 2001-12-11 RU RU2003122219/04A patent/RU2275370C2/en not_active IP Right Cessation
- 2001-12-11 RU RU2003122217/04A patent/RU2282628C2/en not_active IP Right Cessation
-
2003
- 2003-05-27 ZA ZA200304092A patent/ZA200304092B/en unknown
- 2003-05-27 ZA ZA200304095A patent/ZA200304095B/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2005101088A (en) | KATIO SUBSTITUTED DIPHENYLASETIDINONES, METHOD FOR PRODUCING THEM, MEDICINES CONTAINING THESE COMPOUNDS, AND THEIR APPLICATION | |
RU2005128497A (en) | SUBSTITUTED DERIVATIVES OF HEXAHYDROPYRAZINO (1,2-A) PYRIMIDIN-4,7-DION, METHODS FOR THEIR PRODUCTION AND THEIR APPLICATION AS MEDICINES | |
RU2009122470A (en) | NEW BENZyl SUBSTITUTED DERIVATIVES OF 1,4-BENZOTIEPIN-1,1-DIOXIDE, METHOD FOR PRODUCING THEM, MEDICINES CONTAINING SUCH COMPOUNDS, AND THEIR APPLICATION | |
CA2431983A1 (en) | Novel 1,2-diphenylazetidinones, processes for their preparation, medicaments comprising these compounds and their use for treating impaired lipid metabolism | |
JP2004516293A5 (en) | ||
RU2005128499A (en) | NITROGEN DERIVATED HEXAHYDROPYRAZINO (1,2-A) PYRIMIDIN-4, 7-DIONE DERIVATIVES, METHOD FOR PRODUCING THEM AND USE THEM AS A MEDICINAL PRODUCT | |
RU2005101091A (en) | SUBSTITUTED DIPHENYLAZETIDINONES IN CYCLES, METHOD FOR PRODUCING THESE, CONTAINING THESE COMPOUNDS, MEDICINES AND THEIR APPLICATION | |
RU2005101093A (en) | SUBSTITUTED BY ACID GROUPS OF DIPHENYLAZETIDINONES, METHOD FOR PRODUCING THERE CONTAINING THESE COMPOUNDS OF MEDICINES, AND THEIR APPLICATION | |
HRP20041042A2 (en) | Novel substituted sulfamate anticonvulsant derivatives | |
YU31303A (en) | Aryl or heteroaryl fused imidazole compounds as anti- inflammatory and analgesic agents | |
ATE36149T1 (en) | ANTICONVULSIVE SULFAMATE DERIVATIVES. | |
ES480850A1 (en) | Hydantoin compounds, their preparation and pharmaceutical formulations containing them. | |
RU2005133631A (en) | A NEW DIPHENYLAZETIDININE WITH IMPROVED PHYSIOLOGICAL PROPERTIES, METHODS OF ITS PRODUCTION CONTAINING THESE COMPOUNDS MEDICINES AND THEIR APPLICATION | |
HK1042698A1 (en) | New diphenylurea compounds, a process for their preparation and pharmaceutical compositions containing them | |
JP2005533071A5 (en) | ||
HUP0002272A2 (en) | Aroyl-piperazine derivatives, their preparation pharmaceutical compositions containing them and their use | |
RU2006131308A (en) | HETEROCYCLICALLY SUBSTITUTED DERIVATIVES OF 7-AMINO-4-QUINOLON-3-CARBOXYLIC ACIDS, METHOD FOR PRODUCING THEM AND THEIR APPLICATION AS MEDICINES | |
RU98106112A (en) | PROPANOLAMINE DERIVATIVES, METHODS FOR PRODUCING THEREOF, MEDICINES CONTAINING THESE COMPOUNDS AND THEIR USE | |
RU99127433A (en) | ERGOLINE DERIVATIVES AND THEIR APPLICATION AS ANTAGONISTS OF SOMATOSTATIN RECEPTORS | |
RU2004108120A (en) | COMBINED DRUGS FROM ARIL SUBSTITUTED PROPANOLAMINE DERIVATIVES WITH OTHER BIOLOGICALLY ACTIVE SUBSTANCES AND THEIR APPLICATION | |
RU2002133458A (en) | Compounds of piperazine and piperidine | |
RU2006131307A (en) | Cycloalkyl-substituted derivatives of 7-amino-4-quinolone-3-carboxylic acid, a method for their preparation and their use as drugs | |
HUP0203471A2 (en) | Antithrombotic compound, process for their preparation, pharmaceutical compositions containing them and their use | |
CO5160261A1 (en) | SUBSTITUTED BIFENYL DERIVATIVES THAT ARE NK-1 ANTAGONISTS, THEIR SYNTHESIS PROCEDURE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
UA80814C2 (en) | Heterocyclic oxime compounds, a process for their preparation (variants) and pharmaceutical compositions containing them, intermediate |